Synthesis and characterization of biocompatible polyurethanes for controlled release of hydrophobic and hydrophilic drugs

Abstract

Design of biocompatible and biodegradable polymer systems for sustained and controlled release of bioactive agents is critical for numerous biomedical applications. Here, we designed, synthesized, and characterized four polyurethane carrier systems for controlled release of model drugs. These polyurethanes are biocompatible and biodegradable because they consist of biocompatible poly(ethylene glycol) or poly(caprolactone diol) as soft segment, linear aliphatic hexamethylene diisocyanate or symmetrical aliphatic cyclic dicyclohexylmethane-4,4′-diisocyanate as hard segment, and biodegradable urethane linkage. They were characterized with Fourier transform infrared spectroscopy, atomic force microscope, and differential scanning calorimetry, whereas their degradation behaviors were investigated in both phosphate buffered saline and enzymatic solutions. By tuning polyurethane segments, different release profiles of hydrophobic and hydrophilic drugs were obtained in the absence and presence of enzymes. Such difference in release profiles was attributed to a complex interplay among structure, hydrophobicity, and degradability of polyurethanes, the size and hydrophobicity of drugs, and drug-polymer interactions. Different drug-polyurethane combinations modulated the distribution and location of the drugs in polymer matrix, thus inducing different drug release mechanisms. Our results highlight an important role of segmental structure of the polyurethane as an engineering tool to control drug release.

Key words： polyurethanes; controlled release; drug delivery; phase structure; degradation

Acknowledgement

J.Z. thanks financial supports from NSF grants (CAREER Award-0952624 and NSF-CBET-1158447). D.S. acknowledges research support from University at Buffalo Foundation (UBF). This paper is also devoted to Stephanie T. Lopina for her consistent support and mentorship.

References

1 Hashizume R, Fujimoto K L, Hong Y, Amoroso N J, Tobita K, Miki T, Keller B B, Sacks M S, Wagner W R. Morphological and mechanical characteristics of the reconstructed rat abdominal wall following use of a wet electrospun biodegradable polyurethane elastomer scaffold. Biomaterials, 2010, 31(12): 3253–3265

2 McDevitt T C, Woodhouse K A, Hauschka S D, Murry C E, Stayton P S. Spatially organized layers of cardiomyocytes on biodegradable polyurethane films for myocardial repair. Journal of Biomedical Materials Research Part A, 2003, 66A(3): 586–595

3 Guelcher S A. Biodegradable polyurethanes: Synthesis and applications in regenerative medicine. Tissue Engineering Part B Reviews, 2008, 14(1): 3–17

4 Sarkar D, Yang J C, Lopina S T. Structure-property relationship of L-tyrosine-based polyurethanes for biomaterial applications. Journal of Applied Polymer Science, 2008, 108(4): 2345–2355

5 Skarja G A, Woodhouse K A. Structure-property relationships of degradable polyurethane elastomers containing an amino acid-based chain extender. Journal of Applied Polymer Science, 2000, 75(12): 1522–1534

6 Hong Y, Guan J, Fujimoto K L, Hashizume R, Pelinescu A L, Wagner W R. Tailoring the degradation kinetics of poly(ester carbonate urethane)urea thermoplastic elastomers for tissue engineering scaffolds. Biomaterials, 2010, 31(15): 4249–4258

7 Wang Z, Yu L, Ding M, Tan H, Li J, Fu Q. Preparation and rapid degradation of nontoxic biodegradable polyurethanes based on poly(lactic acid)-poly(ethylene glycol)-poly(lactic acid) and l-lysine diisocyanate. Polymer Chemistry, 2011, 2(3): 601–607

8 Sarkar D, Yang J C, Gupta A S, Lopina S T. Synthesis and characterization of L-tyrosine based polyurethanes for biomaterial applications. Journal of Biomedical Materials Research Part A, 2009, 90A(1): 263–271

9 Skarja G A, Woodhouse K A. Synthesis and characterization of degradable polyurethane elastomers containing an amino acid-based chain extender. Journal of Biomaterials Science, Polymer Edition, 1998, 9(3): 271–295

10 Sarkar D, Lopina S T. Oxidative and enzymatic degradations of l-tyrosine based polyurethanes. Polymer Degradation and Stability, 2007, 92(11): 1994–2004

11 Hassan M K, Mauritz K A, Storey R F, Wiggins J S. Biodegradable aliphatic thermoplastic polyurethane based on poly(ϵ-caprolactone) and L-lysine diisocyanate. Journal of Polymer Science Part A: Polymer Chemistry, 2006, 44(9): 2990–3000

12 Guelcher S A, Srinivasan A, Dumas J E, Didier J E, McBride S, Hollinger J O. Synthesis, mechanical properties, biocompatibility, and biodegradation of polyurethane networks from lysine polyisocyanates. Biomaterials, 2008, 29(12): 1762–1775

13 van Minnen B, Stegenga B, van Leeuwen M B M, van Kooten T G, Bos R R M. A long-term in vitro biocompatibility study of a biodegradable polyurethane and its degradation products. Journal of Biomedical Materials Research Part A, 2006, 76A(2): 377–385

14 Park D, Wu W, Wang Y. A functionalizable reverse thermal gel based on a polyurethane/PEG block copolymer. Biomaterials, 2011, 32(3): 777–786

15 Garrett J T, Siedlecki C A, Runt J. Microdomain morphology of poly(urethane urea) multiblock copolymers. Macromolecules, 2001, 34(20): 7066–7070

16 Martin D J, Meijs G F, Gunatillake P A, Yozghatlian S P, Renwick G M. The influence of composition ratio on the morphology of biomedical polyurethanes. Journal of Applied Polymer Science, 1999, 71(6): 937–952

17 Fernández d’Arlas B, Rueda L, de la Caba K, Mondragon I, Eceiza A. Microdomain composition and properties differences of biodegradable polyurethanes based on MDI and HDI. Polymer Engineering & Science, 2008, 48(3): 519–529

18 Hood M A, Wang B, Sands J M, La Scala J J, Beyer F L, Li C Y. Morphology control of segmented polyurethanes by crystallization of hard and soft segments. Polymer, 2010, 51(10): 2191–2198

19 James Korley L T, Liff S M, Kumar N, McKinley G H, Hammond P T. Preferential association of segment blocks in polyurethane nanocomposites. Macromolecules, 2006, 39(20): 7030–7036

20 Petrović Z S, Ferguson J. Polyurethane elastomers. Progress in Polymer Science, 1991, 16(5): 695–836

21 Waletzko R S, Korley L T J, Pate B D, Thomas E L, Hammond P T. Role of increased crystallinity in deformation-induced structure of segmented thermoplastic polyurethane elastomers with PEO and PEO-PPO-PEO soft segments and HDI hard segments. Macromolecules, 2009, 42(6): 2041–2053

22 Takahara A, Hergenrother R W, Coury A J, Cooper S L. Effect of soft segment chemistry on the biostability of segmented polyurethanes. II. In vitro hydrolytic degradation and lipod sorption. Journal of Biomedical Materials Research, 1992, 26(6): 801–818

23 Desai S, Thakore I M, Sarawade B D, Devi S. Effect of polyols and diisocyanates on thermo-mechanical and morphological properties of polyurethanes. European Polymer Journal, 2000, 36(4): 711–725

24 Uhrich K E, Cannizzaro S M, Langer R S, Shakesheff K M. Polymeric systems for controlled drug release. Chemical Reviews, 1999, 99(11): 3181–3198

25 Caldorera-Moore M E, Liechty W B, Peppas N A. Responsive theranostic systems: Integration of diagnostic imaging agents and responsive controlled release drug delivery carriers. Accounts of Chemical Research, 2011, 44(10): 1061–1070

26 Peppas N A, Keys K B, Torres-Lugo M, Lowman A M. Poly(ethylene glycol)-containing hydrogels in drug delivery. Journal of Controlled Release, 1999, 62(1-2): 81–87

27 Langer R. Polymer-controlled drug delivery systems. Accounts of Chemical Research, 1993, 26(10): 537–542

28 Edlund U, Albertsson A C. Degradable polymer microspheres for controlled drug delivery. In: Degradable Aliphatic Polyesters. Berlin: Springer Berlin Heidelberg, 2002, 157: 67–112

29 Kissel T, Li Y, Unger F. ABA-triblock copolymers from biodegradable polyester A-blocks and hydrophilic poly(ethylene oxide) B-blocks as a candidate for in situ forming hydrogel delivery systems for proteins. Advanced Drug Delivery Reviews, 2002, 54(1): 99–134

30 Jain R A. The manufacturing techniques of various drug loaded biodegradable poly(lactide-co-glycolide) (PLGA) devices. Biomaterials, 2000, 21(23): 2475–2490

31 Shen E, Kipper M J, Dziadul B, Lim M K, Narasimhan B. Mechanistic relationships between polymer microstructure and drug release kinetics in bioerodible polyanhydrides. Journal of Controlled Release, 2002, 82(1): 115–125

32 Puttipipatkhachorn S, Nunthanid J, Yamamoto K, Peck G E. Drug physical state and drug-polymer interaction on drug release from chitosan matrix films. Journal of Controlled Release, 2001, 75(1-2): 143–153

33 Yui N, Kataoka K, Yamada A, Sakurai Y, Sanui K, Ogata N. Drug release from monolithic devices of segmented polyether-poly(urethane-urea)s having both hydrophobic and hydrophilic soft segments. Die Makromolekulare Chemie, Rapid Communications, 1986, 7(11): 747–750

34 Yui N, Kataoka K, Yamada A, Sakurai Y. Novel design of microreservoir-dispersed matrices for drug delivery formulations: Regulative drug release from poly(ethylene oxide)- and poly(tetramethylene oxide)-based segmented polyurethanes. Journal of Controlled Release, 1987, 6(1): 329–342

35 Sarkar D, Yang J C, Gupta A S, Lopina S T. Synthesis and characterization of L-tyrosine based polyurethanes for biomaterial applications. Journal of Biomedical Materials Research Part A, 2009, 90A(1): 263–271

36 Yang J C, Zhao C, Hsieh I F, Subramanian S, Liu L, Cheng G, Li L, Cheng S Z D, Zheng J. Strong resistance of poly (ethylene glycol) based L-tyrosine polyurethanes to protein adsorption and cell adhesion. Polymer International, 2012, 61(4): 616–621

37 Guo Q, Knight P T, Mather P T. Tailored drug release from biodegradable stent coatings based on hybrid polyurethanes. Journal of Controlled Release, 2009, 137(3): 224–233

38 Yamaoka T, Makita Y, Sasatani H, Kim S I, Kimura Y. Linear type azo-containing polyurethane as drug-coating material for colon-specific delivery: Its properties, degradation behavior, and utilization for drug formulation. Journal of Controlled Release, 2000, 66(2–3): 187–197

39 Hong Y, Ye S H, Pelinescu A L, Wagner W R. Synthesis, characterization, and paclitaxel release from a biodegradable, elastomeric, poly(ester urethane)urea bearing phosphorylcholine groups for reduced thrombogenicity. Biomacromolecules, 2012, 13(11): 3686–3694

40 Ratner B D, Gladhill K W, Horbett T A. Analysis of in vitro enzymatic and oxidative degradation of polyurethanes. Journal of Biomedical Materials Research, 1988, 22(6): 509–527

41 Christenson E M, Patel S, Anderson J M, Hiltner A. Enzymatic degradation of poly(ether urethane) and poly(carbonate urethane) by cholesterol esterase. Biomaterials, 2006, 27(21): 3920–3926

42 Mishra A, Aswal V K, Maiti P. Nanostructure to microstructure self-assembly of aliphatic polyurethanes: The effect on mechanical properties. The Journal of Physical Chemistry B, 2010, 114(16): 5292–5300

43 Zhou L, Yu L, Ding M, Li J, Tan H, Wang Z, Fu Q. Synthesis and characterization of pH-sensitive biodegradable polyurethane for potential drug delivery applications. Macromolecules, 2011, 44(4): 857–864

44 Hesketh T R, Van Bogart J W C, Cooper S L. Differential scanning calorimetry analysis of morphological changes in segmented elastomers. Polymer Engineering & Science, 1980, 20(3): 190–197

45 Siegmann A, Cohen D, Narkis M. Polyurethane elastomers containing polybutadiene and aliphatic diols: Structure-property relationships. Polymer Engineering & Science, 1987, 27(15): 1187–1194

46 Lee D K, Tsai H B. Properties of segmented polyurethanes derived from different diisocyanates. Journal of Applied Polymer Science, 2000, 75(1): 167–174

47 Ikeda Y, Kohjiya S, Takesako S, Yamashita S. Polyurethane elastomer with PEO-PTMO-PEO soft segment for sustained release of drugs. Biomaterials, 1990, 11(8): 553–560

48 Shen E, Pizsczek R, Dziadul B, Narasimhan B. Microphase separation in bioerodible copolymers for drug delivery. Biomaterials, 2001, 22(3): 201–210

49 Santerre J P, Woodhouse K, Laroche G, Labow R S. Understanding the biodegradation of polyurethanes: From classical implants to tissue engineering materials. Biomaterials, 2005, 26(35): 7457–7470

50 Huang X, Lowe T L. Biodegradable thermoresponsive hydrogels for aqueous encapsulation and controlled release of hydrophilic model drugs. Biomacromolecules, 2005, 6(4): 2131–2139